
Alpine Immune Sciences Investor Relations Material
Latest events

Study Update
Alpine Immune Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alpine Immune Sciences Inc
Access all reports
Alpine Immune Sciences Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory diseases, as well as cancer. The company uses its proprietary platform to engineer protein-based therapies that modulate the immune system to enhance treatment efficacy. Alpine's approach aims to create novel immunotherapies that target immune pathways, offering potential treatments for patients with unmet medical needs in areas such as immuno-oncology and autoimmune disorders. Its pipeline includes a range of drug candidates designed to address these conditions. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
ALPN
Country
🇺🇸 United States